On this page
RYR1
ryanodine receptor 1
The RYR1 gene encodes ryanodine receptor 1, a protein critical for calcium release in skeletal muscle cells, playing a key role in muscle contraction and relaxation. RYR1 provides the blueprint for the ryanodine receptor 1 protein, which functions as a calcium channel in skeletal muscles.
RYR1 is located on the long (q) arm of chromosome 19, at band 19q13.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The RYR1 gene directs the production of ryanodine receptor 1 protein, an essential component for normal skeletal muscle function. This protein forms a calcium release channel within muscle cells, which is fundamental for initiating muscle contraction. Understanding RYR1 is important for its role in both typical physiological processes and its association with several inherited muscle disorders.
Conditions linked to RYR1 variants include malignant hyperthermia susceptibility, central core disease, congenital fibre-type disproportion myopathy, and multi-minicore disease. These conditions frequently involve muscle weakness or abnormal reactions to certain anaesthetics, highlighting the gene's significance in neuromuscular health.
What the gene does
The RYR1 gene encodes the ryanodine receptor 1 (RYR1 channel) protein, a key player in excitation-contraction (E-C) coupling within skeletal muscles. This process converts electrical signals into muscle contraction. The RYR1 channel is embedded in the membrane of the sarcoplasmic reticulum, an intracellular compartment responsible for storing calcium ions.
When a muscle receives a signal to contract, the RYR1 channel opens, releasing stored calcium ions into the cell's cytoplasm. This influx of calcium ions triggers muscle fibres to contract, thereby facilitating movement. The proper functioning of the RYR1 channel is therefore crucial for the coordinated tensioning and relaxation of skeletal muscles. Variants in this gene can disrupt calcium regulation, leading to impaired muscle function.
Video: Genetics 101
Chromosome location
The RYR1 gene is situated on chromosome 19 at position 19q13.2. This genomic location specifies where the gene is found within the human genome. Its precise placement assists in genetic mapping and understanding the inheritance patterns of conditions associated with RYR1.
Protein structure
The ryanodine receptor 1 protein is a large protein composed of 5038 amino acids. It features several important structural domains. These include five MIR domains (MIR 1-5), three B30.2/SPRY domains (B30.2/SPRY 1-3), and an interaction region with FKBP1A. The protein also contains approximately six repeats within its central region and several disordered regions.
Key variants
Variants within the RYR1 gene can significantly impact the structure and function of the ryanodine receptor 1 protein. These genetic changes can alter how calcium is released within muscle cells, leading to a range of muscle-related conditions. The types of variants vary, from single amino acid substitutions to changes that result in truncated proteins, each potentially affecting the protein's ability to regulate calcium effectively.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.10450dup | p.Ile3484fs | Pathogenic/Likely pathogenic | ★★☆☆ | Central core myopathy |
c.2200C>T | p.Gln734Ter | Pathogenic/Likely pathogenic | ★★☆☆ | RYR1-related disorder |
c.3883C>T | p.Gln1295Ter | Pathogenic/Likely pathogenic | ★★☆☆ | RYR1-related disorder |
c.11653C>T | p.Arg3885Ter | Pathogenic | ★☆☆☆ | RYR1-related disorder |
c.12511G>T | p.Glu4171Ter | Pathogenic | ★☆☆☆ | RYR1-related disorder |
c.13048del | p.Ala4350fs | Pathogenic | ★☆☆☆ | RYR1-related disorder |
c.13659+1del | - | Pathogenic | ★☆☆☆ | RYR1-related disorder |
c.13671_13672delinsGT | p.Arg4558Trp | Pathogenic | ★☆☆☆ | RYR1-related disorder |
c.13867dup | p.Asp4623fs | Pathogenic | ★☆☆☆ | RYR1-related disorder |
c.5804_5805del | p.Val1935fs | Pathogenic | ★☆☆☆ | Hypotonic infant |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the RYR1 gene are linked to several inherited conditions that primarily affect skeletal muscles. These include Central core disease, characterised by muscle weakness, and Congenital fibre-type disproportion myopathy, which causes generalised muscle weakness. The gene is also a major genetic risk factor for Malignant hyperthermia susceptibility, a severe reaction to certain anaesthetics, and is associated with atypical forms of Multi-minicore disease.
Inheritance pattern
Conditions caused by pathogenic RYR1 variants typically follow autosomal dominant inheritance.
Each child of an affected parent has a 50% chance of inheriting the pathogenic variant, regardless of sex.
UK clinical status
In the UK, the RYR1 gene is reviewed by the NHS Genomic Medicine Service through its PanelApp framework. It is currently listed on several 'green' panels, indicating strong evidence for its association with specific conditions. These panels include Malignant hyperthermia, Congenital myopathy, Acute rhabdomyolysis, Arthrogryposis, Foetal anomalies, Foetal hydrops, Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies, Rhabdomyolysis and metabolic muscle disorders, and Skeletal Muscle Channelopathies.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main function of the RYR1 gene?
The RYR1 gene provides instructions for making the ryanodine receptor 1 protein, which acts as a calcium release channel in skeletal muscle cells. This channel is crucial for initiating muscle contraction and relaxation.
What conditions are associated with RYR1 gene variants?
Variants in the RYR1 gene are associated with conditions such as Central core disease, Congenital fibre-type disproportion myopathy, Malignant hyperthermia susceptibility, and Multi-minicore disease, all of which affect muscle function.
How does RYR1 relate to malignant hyperthermia?
RYR1 gene variants are the most common genetic risk factor for malignant hyperthermia. This condition is a severe reaction to certain anaesthetic drugs, characterised by high fever and muscle rigidity, due to uncontrolled calcium release in muscle cells.
References
- Riazi S, Kraeva N, Hopkins PM. Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept. Anesthesiology. 2018. PMID: 28902675
- Amburgey K, Bailey A, Hwang JH. Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet journal of rare diseases. 2013. PMID: 23919265
- Clarke NF, Waddell LB, Cooper ST. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Human mutation. 2010. PMID: 20583297
- Lyfenko AD, Ducreux S, Wang Y. Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms. Human mutation. 2007. PMID: 16958053
- Zorzato F, Jungbluth H, Zhou H. Functional effects of mutations identified in patients with multiminicore disease. IUBMB life. 2007. PMID: 17365175
- Zhou H, Jungbluth H, Sewry CA. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain : a journal of neurology. 2007. PMID: 17483490
- Jungbluth H. Central core disease. Orphanet journal of rare diseases. 2007. PMID: 17504518
- Jungbluth H. Multi-minicore Disease. Orphanet journal of rare diseases. 2007. PMID: 17631035
- Rossi AE, Dirksen RT. Sarcoplasmic reticulum: the dynamic calcium governor of muscle. Muscle & nerve. 2006. PMID: 16477617
- Wu S, Ibarra MC, Malicdan MC. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain : a journal of neurology. 2006. PMID: 16621918
- Robinson R, Carpenter D, Shaw MA. Mutations in RYR1 in malignant hyperthermia and central core disease. Human mutation. 2006. PMID: 16917943
- Avila G. Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved. Cell calcium. 2005. PMID: 15589992
- Treves S, Anderson AA, Ducreux S. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscular disorders : NMD. 2005. PMID: 16084090
- Lyfenko AD, Goonasekera SA, Dirksen RT. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease. Biochemical and biophysical research communications. 2004. PMID: 15336973
- Adam MP, Bick S, Mirzaa GM. Nonsyndromic Malignant Hyperthermia Susceptibility. 1993. PMID: 20301325